Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Director · EXECUTIVE CHAIRMAN | November 10, 2021 | December 08, 2021 |
| CATERPILLAR INCCAT · Entity 2808 | Director | March 01, 2022 | March 02, 2022 |
| MCDONALDS CORPMCD · Entity 2849 | Director | December 31, 2025 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date November 10, 2021 · Filed December 08, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 3,092,852 |
Ending reported balance
After 2021-11-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-11-10 · Gift · Disposed 693 · Balance 3,103,252 Row 2 · 2021-11-12 · Gift · Disposed 10,400 · Balance 3,092,852 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 35,789 |
Reported balance
Holding disclosure · report date 2021-11-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 35,789 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021.
CATERPILLAR INC
Report date March 01, 2022 · Filed March 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,382 |
Reported balance
After 2022-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-01 · Tax withholding · Disposed 293 · Balance 8,382 F1: Includes adjustments for dividends accrued. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes adjustments for dividends accrued.
MCDONALDS CORP
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 23,286.12 |
Reported balance
After 2025-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-31 · Grant · Acquired 670.75 · Balance 23,286.12 F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan"). F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F4: Includes shares acquired through dividend reinvestment. |
| Common StockSEC Table I · non-derivative | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan").
F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation.
F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board.
F4: Includes shares acquired through dividend reinvestment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 2,780 | $43.34 | $120,471.30 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 20 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,686,376 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 12,879 | $43.31 | $557,725.10 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 19 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,683,596 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 7,800 | $43.32 | $337,896.00 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 18 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,670,717 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 500 | $43.39 | $21,695.00 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 17 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,662,917 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 1,900 | $43.29 | $82,251.00 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 16 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,662,417 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 500 | $43.26 | $21,630.50 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,660,517 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 9,600 | $43.12 | $413,952.00 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,660,017 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 12,641 | $43.13 | $545,206.33 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,650,417 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 200 | $43.26 | $8,652.50 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,637,776 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 1,700 | $43.30 | $73,610.00 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,637,576 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 2,800 | $43.26 | $121,114.00 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,635,876 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 100 | $43.12 | $4,312.25 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,633,076 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 5,979 | $43.18 | $258,143.33 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,632,976 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 4,101 | $43.10 | $176,732.60 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,626,997 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 10,899 | $43.11 | $469,855.89 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,622,896 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 42,445 | $43.27 | $1,836,595.15 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,611,997 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 1,772 | $43.17 | $76,488.38 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,569,552 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 2,300 | $43.21 | $99,371.50 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,567,780 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 200 | $43.26 | $8,652.50 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,565,480 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 18,000 | $43.37 | $780,660.00 |
DisclosureSEC source: 0001179110-16-027936 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,565,280 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 200 | $43.37 | $8,674.00 |
DisclosureSEC source: 0001179110-16-027937 · edgar.xml · nonDerivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,742,017 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 5,300 | $43.30 | $229,490.00 |
DisclosureSEC source: 0001179110-16-027937 · edgar.xml · nonDerivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,741,817 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 600 | $43.39 | $26,031.00 |
DisclosureSEC source: 0001179110-16-027937 · edgar.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,736,517 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 100 | $43.33 | $4,333.25 |
DisclosureSEC source: 0001179110-16-027937 · edgar.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,735,917 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 3,000 | $43.35 | $130,035.00 |
DisclosureSEC source: 0001179110-16-027937 · edgar.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,735,817 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 2,000 | $43.35 | $86,700.00 |
DisclosureSEC source: 0001179110-16-027937 · edgar.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,732,817 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 4,800 | $43.37 | $208,152.00 |
DisclosureSEC source: 0001179110-16-027937 · edgar.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730,817 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 500 | $43.38 | $21,690.00 |
DisclosureSEC source: 0001179110-16-027937 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,726,017 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 900 | $43.32 | $38,983.50 |
DisclosureSEC source: 0001179110-16-027937 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,725,517 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 300 | $43.28 | $12,984.00 |
DisclosureSEC source: 0001179110-16-027937 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,724,617 Read SEC document |
| July 25, 2016 Filed Jul 27, 2016 20:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 233 | $43.30 | $10,089.48 |
DisclosureSEC source: 0001179110-16-027937 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,724,317 Read SEC document |
| June 30, 2016 Filed Jul 5, 2016 17:44 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantPhantom Stock Units · Derivative | 567 | $74.91 | $42,473.97 |
DisclosureSEC source: 0000018230-16-000589 · edgar.xml · derivative · entry 1 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,095 Underlying: Common Stock · 567 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit is the economic equivalent of one share of Caterpillar Inc. common stock. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: The phantom stock units were acquired under the Caterpillar Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F3 · derivative.expiration_date: The phantom stock units were acquired under the Caterpillar Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| March 31, 2016 Filed Apr 4, 2016 21:59 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantPhantom Stock Units · Derivative | 554 | $76.69 | $42,486.26 |
DisclosureSEC source: 0000018230-16-000493 · edgar.xml · derivative · entry 1 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,479 Underlying: Common Stock · 554 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit is the economic equivalent of one share of Caterpillar Inc. common stock. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: The phantom stock units were acquired under the Caterpillar Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F3 · derivative.expiration_date: The phantom stock units were acquired under the Caterpillar Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| March 07, 2016 Filed Mar 9, 2016 21:50 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantCommon Stock | 1,672 | $0.00 | $0.00 |
DisclosureSEC source: 0000018230-16-000464 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,977 Read SEC document |
| March 02, 2016 Filed Mar 3, 2016 22:12 UTC | CATERPILLAR INC CAT · Entity 2808 | Tax withholdingCommon Stock | 653 | $69.07 | $45,102.71 |
DisclosureSEC source: 0000018230-16-000421 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,305 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 70,354 | $39.52 | $2,780,390.08 |
DisclosureSEC source: 0001179110-16-020691 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,460,517 Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,198,630 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019932 · edgar.xml · derivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,198,630 Underlying: Common shares · 1,198,630 shares Expires 2026-02-18 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 399,544 on 02/19/2017, 399,543 on 02/19/2018, and 399,543 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 136,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019932 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,530,871 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| December 31, 2015 Filed Jan 5, 2016 18:50 UTC | MCDONALDS CORP MCD · Entity 2849 | GrantPhantom Stock · Derivative | 1,185.04 | $118.14 | $140,000.63 |
DisclosureSEC source: 0001140361-16-046487 · doc1.xml · derivative · entry 2 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,771.7 Underlying: Common Stock · 1,185.04 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock and shall be settled in cash, pursuant to the Directors' Deferred Compensation Plan (the "Plan"). F2 · kind: Acquisition of phantom stock pursuant to the Plan in transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3 · derivative.exercise_date: Payment of phantom stock may be deferred until the earlier of the director's retirement date or other termination from the Board or a specific future date pursuant to an election. F3 · derivative.expiration_date: Payment of phantom stock may be deferred until the earlier of the director's retirement date or other termination from the Board or a specific future date pursuant to an election. F4 · balance_after: Includes shares acquired through dividend reinvestment. Read SEC document |
| December 31, 2015 Filed Jan 5, 2016 20:43 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantPhantom Stock Units · Derivative | 310 | $68.52 | $21,241.20 |
DisclosureSEC source: 0000018230-16-000365 · edgar.xml · derivative · entry 1 WHITE MILES D · CIK 0001239129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,880 Underlying: Common Stock · 310 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit is the economic equivalent of one share of Caterpillar Inc. common stock. F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation. F3 · derivative.exercise_date: The phantom stock units were acquired under the Caterpillar Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F3 · derivative.expiration_date: The phantom stock units were acquired under the Caterpillar Inc. Director's Deferred Compensation Plan and are to be settled 100% in cash upon the reporting person's retirement or separation from service. F4 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 438,000 | $0.00 Strike: $21.22 | $0.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · derivative · entry 23 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 438,000 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,900 | $46.05 | $87,495.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,394,153 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $46.05 | $13,813.50 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,396,053 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $46.04 | $59,852.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,396,353 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,100 | $46.04 | $50,638.50 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,397,653 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 14,439 | $46.03 | $664,627.17 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,398,753 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $46.03 | $9,205.50 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,413,192 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,617 | $46.03 | $120,447.43 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,413,392 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 12,150 | $46.02 | $559,143.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,416,009 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,921 | $46.02 | $134,409.82 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428,159 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.